Long-Term Results After Drug-Eluting Versus Bare-Metal Stent Implantation in Saphenous Vein Grafts: Randomized Controlled Trial

被引:5
|
作者
Fahrni, Gregor [1 ]
Farah, Ahmed [2 ,3 ]
Engstrom, Thomas [4 ]
Galatius, Soren [5 ,6 ]
Eberli, Franz [7 ]
Rickenbacher, Peter [1 ]
Conen, David [1 ,8 ]
Mueller, Christian [1 ]
Pfister, Otmar [1 ]
Twerenbold, Raphael [1 ]
Coslovsky, Michael [1 ]
Cattaneo, Marco [1 ]
Kaiser, Christoph [1 ]
Mangner, Norman [9 ,10 ]
Schuler, Gerhard [10 ]
Pfisterer, Matthias [1 ]
Moebius-Winkler, Sven [10 ,11 ]
Jeger, Raban V. [1 ]
机构
[1] Univ Hosp, Basel, Switzerland
[2] Klinikum Westfalen, Dortmund, Germany
[3] Cent Clin, Bad Berka, Germany
[4] Rigshosp, Copenhagen, Denmark
[5] Bispebjerg Hosp, Copenhagen, Denmark
[6] Gentofte Univ Hosp, Hellerup, Denmark
[7] Triemli Hosp, Zurich, Switzerland
[8] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada
[9] Tech Univ Dresden, Herzzentrum Dresden, Dresden, Germany
[10] Univ Leipzig, Heart Ctr, Leipzig, Germany
[11] Univ Jena, Jena, Germany
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2020年 / 9卷 / 20期
基金
瑞士国家科学基金会;
关键词
bare-metal stent; coronary artery bypass; drug-eluting stent; saphenous vein graft;
D O I
10.1161/JAHA.120.017434
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Efficacy data on drug-eluting stents (DES) versus bare-metal stents (BMS) in saphenous vein grafts are controversial. We aimed to compare DES with BMS among patients undergoing saphenous vein grafts intervention regarding long-term outcome. Methods and Results In this multinational trial, patients were randomized to paclitaxel-eluting or BMS. The primary end point was major adverse cardiac events (cardiac death, nonfatal myocardial infarction, and target-vessel revascularization at 1 year. Secondary end points included major adverse cardiac events and its individual components at 5-year follow-up. One hundred seventy-three patients were included in the trial (89 DES versus 84 BMS). One-year major adverse cardiac event rates were lower in DES compared with BMS (2.2% versus 16.0%, hazard ratio, 0.14; 95% CI, 0.03-0.64,P=0.01), which was mainly driven by a reduction of subsequent myocardial infarctions and need for target-vessel revascularization. Five-year major adverse cardiac event rates remained lower in the DES compared with the BMS arm (35.5% versus 56.1%, hazard ratio, 0.40; 95% CI, 0.23-0.68,P<0.001). A landmark-analysis from 1 to 5 years revealed a persistent benefit of DES over BMS (hazard ratio, 0.33; 95% CI, 0.13-0.74,P=0.007) in terms of target-vessel revascularization. More patients in the BMS group underwent multiple target-vessel revascularization procedures throughout the study period compared with the DES group (DES 1.1% [n=1] versus BMS 9.5% [n=8],P=0.013). Enrollment was stopped before the target sample size of 240 patients was reached. Conclusions In this randomized controlled trial with prospective long-term follow-up of up to 5 years, DES showed a better efficacy than BMS with sustained benefits over time. DES may be the preferred strategy in this patient population. Registration URL:; Unique identifier: NCT00595647.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Long-Term Outcomes of Drug-Eluting Stents Versus Bare-Metal Stents in Saphenous Vein Graft Disease: Results from the Prairie "Real World" Stent Registry
    Goswami, Nilesh J.
    Gaffigan, Matthew
    Pfeiffer, Amanda M.
    Moore, Anna L.
    Markwell, Stephen J.
    Shelton, Marc E.
    Mishkel, Gregory J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 138I - 138I
  • [22] Long-term clinical outcomes after sirolimus-eluting Stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents
    Lee, Cheol Whan
    Kim, Sang-Hyun
    Suh, Jon
    Park, Duk-Woo
    Lee, Seung-Hwan
    Kim, Young-Hak
    Hong, Myeong-Ki
    Kim, Jae-Joong
    Park, Seong-Wook
    Park, Seung-Jung
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2008, 71 (05) : 594 - 598
  • [23] Late angiographic stent thrombosis (LAST) after bare-metal stent versus drug-eluting stent implantation
    Park, DW
    Park, SW
    Jeong, YH
    Hwang, ES
    Lee, SW
    Kim, YH
    Lee, BK
    Lee, CW
    Hong, MK
    Kim, JJ
    Park, SJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 317A - 317A
  • [24] Long-term clinical outcomes and stent thrombosis after drug-eluting stent and versus bare-metal stent for acute myocardial infarction
    Lee, Seung-Whan
    Suh, Jon
    Park, Duk-Woo
    Jung, In Hyun
    Kim, Young-Hak
    Lee, Cheol Whan
    Hong, Myeong-Ki
    Kim, Jae-Joong
    Park, SLong-Wook
    Park, Seung-Jung
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 213L - 213L
  • [25] Drug-eluting versus bare-metal stents in saphenous vein graft lesions Reply
    Mehilli, Julinda
    Kastrati, Adnan
    Richardt, Gert
    Neumann, Franz-Josef
    Schoemig, Albert
    LANCET, 2012, 379 (9816): : 615 - 616
  • [26] Drug-eluting stents versus bare-metal stents for saphenous vein graft interventions
    Shah, Rahman
    Hesterberg, Kirstin
    JOURNAL OF THORACIC DISEASE, 2019, 11 : S1257 - S1260
  • [27] Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions
    Han Ya-ling
    Zhang Jian
    Li Yi
    Wang Shou-li
    Jing Quan-min
    Yi Xian-hua
    Ma Ying-yan
    Luan Bo
    Wang Geng
    Wang Bin
    CHINESE MEDICAL JOURNAL, 2009, 122 (06) : 643 - 647
  • [28] Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions
    HAN Yaling ZHANG Jian LI Yi WANG Shouli JING Quanmin YI Xianhua MA Yingyan LUAN Bo WANG Geng WANG Bin Department of CardiologyShenyang Northern HospitalShenyangLiaoning China
    中华医学杂志(英文版), 2009, (06) : 643 - 647
  • [29] Comparison of the frequency of stent thrombosis after bare-metal stent with drug-eluting stent implantation
    Furugen, M.
    Kuriyama, N.
    Ogata, K.
    Kimura, T.
    Fukushima, Y.
    Inoue, Y.
    Nakama, T.
    Sagara, S.
    Matsuyama, A.
    Shibata, Y.
    EUROPEAN HEART JOURNAL, 2013, 34 : 558 - 558
  • [30] Drug-eluting versus bare-metal stents: long-term outcomes in Sweden
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 (7): : 349 - 349